138 related articles for article (PubMed ID: 30548113)
21. Synthesis and activity mechanism of some novel 2-substituted benzothiazoles as hGSTP1-1 enzyme inhibitors.
Bolelli K; Musdal Y; Aki-Yalcin E; Mannervik B; Yalcin I
SAR QSAR Environ Res; 2017 Nov; 28(11):927-940. PubMed ID: 29206502
[TBL] [Abstract][Full Text] [Related]
22. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells.
van Zanden JJ; Geraets L; Wortelboer HM; van Bladeren PJ; Rietjens IM; Cnubben NH
Biochem Pharmacol; 2004 Apr; 67(8):1607-17. PubMed ID: 15041478
[TBL] [Abstract][Full Text] [Related]
23. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival.
Sánchez-Gómez FJ; Gayarre J; Avellano MI; Pérez-Sala D
Arch Biochem Biophys; 2007 Jan; 457(2):150-9. PubMed ID: 17169324
[TBL] [Abstract][Full Text] [Related]
24. Identification of tyrosine 79 in the tocopherol binding site of glutathione S-transferase pi.
Ralat LA; Colman RF
Biochemistry; 2006 Oct; 45(41):12491-9. PubMed ID: 17029404
[TBL] [Abstract][Full Text] [Related]
25. The synthesis of alpha,beta-unsaturated carbonyl derivatives with the ability to inhibit both glutathione S-transferase P1-1 activity and the proliferation of leukemia cells.
Zhao G; Liu C; Wang R; Song D; Wang X; Lou H; Jing Y
Bioorg Med Chem; 2007 Apr; 15(7):2701-7. PubMed ID: 17287120
[TBL] [Abstract][Full Text] [Related]
26. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
[TBL] [Abstract][Full Text] [Related]
27. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
Wang W; Liu G; Zheng J
Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
[TBL] [Abstract][Full Text] [Related]
28. Cyclopentenone prostaglandins with dienone structure promote cross-linking of the chemoresistance-inducing enzyme glutathione transferase P1-1.
Sánchez-Gómez FJ; Díez-Dacal B; Pajares MA; Llorca O; Pérez-Sala D
Mol Pharmacol; 2010 Oct; 78(4):723-33. PubMed ID: 20631055
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of 2-substituted-5-(4-nitrophenylsulfonamido)benzoxazoles as human GST P1-1 inhibitors, and description of the binding site features.
Ertan-Bolelli T; Musdal Y; Bolelli K; Yilmaz S; Aksoy Y; Yildiz I; Aki-Yalcin E; Yalcin I
ChemMedChem; 2014 May; 9(5):984-92. PubMed ID: 24677708
[TBL] [Abstract][Full Text] [Related]
30. Erk-Creb pathway suppresses glutathione-S-transferase pi expression under basal and oxidative stress conditions in zebrafish embryos.
Hrubik J; Glisic B; Fa S; Pogrmic-Majkic K; Andric N
Toxicol Lett; 2016 Jan; 240(1):81-92. PubMed ID: 26494252
[TBL] [Abstract][Full Text] [Related]
31. Binding of GSH conjugates to π-GST: a cross-docking approach.
Lannutti F; Marrone A; Re N
J Mol Graph Model; 2012 Feb; 32():9-18. PubMed ID: 22014382
[TBL] [Abstract][Full Text] [Related]
32. TLK-199 (Telik).
Hamilton D; Batist G
IDrugs; 2005 Aug; 8(8):662-9. PubMed ID: 16044376
[TBL] [Abstract][Full Text] [Related]
33. Interactions of prostaglandin A2 with the glutathione-mediated biotransformation system.
van Iersel ML; Cnubben NH; Smink N; Koeman JH; van Bladeren PJ
Biochem Pharmacol; 1999 Jun; 57(12):1383-90. PubMed ID: 10353259
[TBL] [Abstract][Full Text] [Related]
34. FDA-approved drugs and other compounds tested as inhibitors of human glutathione transferase P1-1.
Musdal Y; Hegazy UM; Aksoy Y; Mannervik B
Chem Biol Interact; 2013 Sep; 205(1):53-62. PubMed ID: 23769903
[TBL] [Abstract][Full Text] [Related]
35. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways.
Ruscoe JE; Rosario LA; Wang T; Gaté L; Arifoglu P; Wolf CR; Henderson CJ; Ronai Z; Tew KD
J Pharmacol Exp Ther; 2001 Jul; 298(1):339-45. PubMed ID: 11408560
[TBL] [Abstract][Full Text] [Related]
36. Possible prenatal impact of sertraline on human placental glutathione S-transferase-π.
Dalmizrak O; Kulaksiz-Erkmen G; Ozer N
Hum Exp Toxicol; 2012 May; 31(5):457-64. PubMed ID: 22144728
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of 2-substituted-5-(4-trifluoromethylphenyl-sulphonamido)benzoxazole derivatives as human GST P1-1 inhibitors.
Ertan-Bolelli T; Bolelli K; Musdal Y; Yildiz I; Aki-Yalcin E; Mannervik B; Yalcin I
Artif Cells Nanomed Biotechnol; 2018 May; 46(3):510-517. PubMed ID: 28503938
[TBL] [Abstract][Full Text] [Related]
38. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y
J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
[TBL] [Abstract][Full Text] [Related]
39. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
[TBL] [Abstract][Full Text] [Related]
40. The synthesis of ethacrynic acid thiazole derivatives as glutathione S-transferase pi inhibitors.
Li T; Liu G; Li H; Yang X; Jing Y; Zhao G
Bioorg Med Chem; 2012 Apr; 20(7):2316-22. PubMed ID: 22370342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
